Lataa...
MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
Osteosarcoma is the most common primary bone tumour. Increasing evidence has demonstrated the pathogenic role of microRNA (miRNAs) dysregulation in tumour development. miR‐379 was previously reported to function as an oncogenic or tumour‐suppressing miRNA in a tissue‐dependent manner. However, its f...
Tallennettuna:
| Julkaisussa: | J Cell Mol Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5264134/ https://ncbi.nlm.nih.gov/pubmed/27781416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12966 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|